Natco Pharma seeks compulsory license for COVID-19 drug

Hyderabad-based Natco Pharma said it has decided to seek a compulsory license from the government of India to manufacture Baricitinib tablets to treat COVID-19 patients. Compulsory licensing is an internationally recognized patent provision under which the government of a country can give permission to a company to manufacture a patent-protected product for emergency use if […]